Vijesh Sreedhar Kuttiatt
Biographic Data
| ID | 7044111 |
|---|---|
| NAME | Vijesh Sreedhar Kuttiatt |
| GIVEN NAMES | Vijesh Sreedhar |
| FAMILY NAME | Kuttiatt |
| SIGNATURE | KUTTIATT V S |
| AFFILIATIONS | Vector Control Research Centre |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Unveiling the gendered abyss
Addressing the factors that impact the lived experiences of women with lymphatic filariasis is an essential but complex task that requires positive changes across various domains. Targeted mental health interventions and robust family support systems can play a pivotal role in improving the health outcomes of affected individuals. Also, gender-informed intersectional research on the illness experiences of women with LF can give valuable insights …
Impediments to compliance during filariasis mass drug administration—Observations and recommendations to accelerate filariasis elimination in India
Impediments to compliance during filariasis mass drug administration—Observations and recommendations to accelerate filariasis elimination in India
Vaccination coverage and breakthrough infections of Covid-19 during the second wave among staff of selected medical institutions in India
India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a potent tool to control and end the pandemic in addition to other control measures. India rolled out its vaccination programme on January 16, 2021, initi…
No prominent works on this page.
Vaccination coverage and breakthrough infections of Covid-19 during the second wave among staff of selected medical institutions in India
India experienced the second wave of SARS-CoV-2 infection from April 3 to June 10, 2021. During the second wave, Delta variant B.1617.2 emerged as the predominant strain, spiking cases from 12.5 million to 29.3 million (cumulative) by the end of the surge in India. Vaccines against COVID-19 are a potent tool to control and end the pandemic in addition to other control measures. India rolled out its vaccination programme on January 16, 2021, initi…
Impediments to compliance during filariasis mass drug administration—Observations and recommendations to accelerate filariasis elimination in India
Impediments to compliance during filariasis mass drug administration—Observations and recommendations to accelerate filariasis elimination in India
Unveiling the gendered abyss
Addressing the factors that impact the lived experiences of women with lymphatic filariasis is an essential but complex task that requires positive changes across various domains. Targeted mental health interventions and robust family support systems can play a pivotal role in improving the health outcomes of affected individuals. Also, gender-informed intersectional research on the illness experiences of women with LF can give valuable insights …
Medicine (3 works) · Filariasis (2 works) · Lymphatic filariasis (2 works) · Parasitic Diseases Research and Treatment (2 works) · COVID-19 epidemiological studies (1 works) · Disease (1 works) · Elephantiasis (1 works) · Emergency Medicine (1 works) · Environmental health (1 works) · Family medicine (1 works)